ASA: No Drop in Recurrent Stroke Seen With Apixaban After Cr

For patients with recent cryptogenic stroke and evidence of atrial cardiopathy, the risk for recurrent stroke is not reduced with apixaban.

Related Keywords

New York , United States , Phoenix , Arizona , American , Hooman Kamel , American Stroke Association International Conference , Journal Of The American Medical Association , Healthday News , American Medical Association , Weill Cornell Medicine , New York City , Pfizer Alliance , Roche Diagnostics ,